«New research has found that millions of patients could benefit from genetic screening before being prescribed common medicines.

The research, led by the University of East Anglia (UEA) in collaboration with academics at Boots UK and Leiden University in the Netherlands, considered 2019 NHS dispensing data to determine how many patients started new prescriptions each year.

The researchers found that for medicines where there are known drug-gene interactions, including antidepressants, antibiotics, stomach ulcer treatments and painkillers, in 21.1% occasions there was a potential for genetic screening.»

Article written by Lucy Parsons